Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.

导出 LinkOut

翻译打印收藏纠错

第一作者： Michael,Herdman

第一单位： Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. mherdman@ohe.org.

作者： Michael,Herdman ^[1] ; Cicely,Kerr ^[2] ; Marco,Pavesi ^[3] ; Jamie,Garside ^[2] ; Andrew,Lloyd ^[4] ; Patricia,Cubi-Molla ^[5] ; Nancy,Devlin ^[5]

作者单位： Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. mherdman@ohe.org. ^[1] Janssen-Cilag Ltd, High Wycombe, UK. ^[2] Data Management Centre, European Foundation for the Study of Chronic Liver Failure (EF-CLIF), Barcelona, Spain. ^[3] Acaster Lloyd Consulting Ltd, London, UK. ^[4] Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. ^[5]

关键词 Cancer Condition-specific non-preference-based measures Generic preference-based measures Quality of life Utilities

DOI 10.1186/s41687-020-0185-3

PMID 32219576

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of patient-reported outcomes

2020年4卷1期

22页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.

Journal of patient-reported outcomes

相似文献

Journal of patient-reported outcomes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.

Journal of patient-reported outcomes

相似文献

Journal of patient-reported outcomes

相关期刊

检索历史清除